Stroke/Vascular Neurology News

Implementation of an artificial intelligence platform led to improved workflow and significantly improved response time for those with ischemic stroke, according to a poster from the International Stroke Conference.

Treatment with selective serotonin/serotonin-norepinephrine reuptake inhibitors after ischemic stroke was associated with low risk of bleeding events at 1 year, according to a presenter at the International Stroke Conference.

Patients who experience acute ischemic stroke may be at elevated risk for heart attack within 1 year of their index event, according to study findings presented during the International Stroke Conference.

Black women as young as 24 years diagnosed with hypertension may have up to a threefold greater risk for stroke at midlife vs. women without hypertension, researchers reported.

Tenecteplase IV therapy for individuals who suffered ischemic stroke was nonsuperior to placebo, according to research in the New England Journal of Medicine.

Adults with mild stroke had higher odds of maintaining similar levels of physical activity or being more active with greater resources available in their area, according to research presented at the International Stroke Conference.

Patients who are hospitalized with stroke-like symptoms, but do not experience a stroke, may yet develop PTSD at a higher rate than patients who actually had a stroke, a speaker reported.

Individuals who suffered acute ischemic stroke in disadvantaged neighborhoods had twice the risk of poor recovery compared with those living in areas with improved conditions, according a speaker at the International Stroke Conference.

For individuals who suffer an ischemic stroke, IV administration of tenecteplase within a mobile stroke unit favorably compared with alteplase perfusion, according to preliminary data presented at the International Stroke Conference.

Anticoagulation with apixaban after cryptogenic stroke with evidence of atrial cardiopathy and no atrial fibrillation did not prevent recurrent stroke compared with aspirin, researchers reported.